M. Isaji et al., Inhibitory effects of tranilast on the proliferation and functions of human pterygium-derived fibroblasts, CORNEA, 19(3), 2000, pp. 364-368
Purpose. We studied the possibility that tranilast, an antiallergic and ant
iproliferative drug, may be beneficial for the treatment of pterygium. Meth
ods. Pterygium-derived cells were identified by immunohistochemical methods
. Growth rate of pterygium-derived cells was determined by using a hemocyto
meter. Chemotaxis was determined in a microchemotaxis chamber. Pterygium-de
rived cells were cultured on floating collagen gel, and the contracted diam
eter was measured. Collagen synthesis by pterygium-derived cells was determ
ined by the collagenase digestive method. Tranilast was added to the cultur
e medium at final concentrations of 0, 12.5, 25, 50, and 100 mu g/ml. Resul
ts, Pterygium-derived cells were stained with anti-prolylhydroxylase and an
ti-a-smooth muscle actin, and identified as fibroblasts. Tranilast inhibite
d the proliferation and chemotaxis of pterygium-derived fibroblasts, and th
e collagen-gel contraction induced by these cells, but it exerted no inhibi
tory action on collagen synthesis by pterygium-derived fibroblasts. Conclus
ion, Tranilast may be useful for suppressing the recurrence and, possibly,
the development of pterygium.